These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31670495)

  • 1. Bioinformatics analysis of key pathways and genes in osteosarcoma development.
    Yang Z; Zeng K; Shen Y; Yang X; Sun J; Zhu G
    Panminerva Med; 2023 Sep; 65(3):401-402. PubMed ID: 31670495
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
    Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
    J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis.
    Dong B; Wang G; Yao J; Yuan P; Kang W; Zhi L; He X
    Gene; 2017 Sep; 628():32-37. PubMed ID: 28687333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis.
    Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L
    Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioinformatics analysis of differently expressed genes in osteoblastic sarcoma and screening of key genes].
    Shen RK; Huang Z; Zhu X; Lin JH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):147-154. PubMed ID: 35184458
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of hub genes specific to pulmonary metastasis in osteosarcoma through integrated bioinformatics analysis.
    Chai Y; Xu L; He R; Zhong L; Wang Y
    Technol Health Care; 2022; 30(3):735-745. PubMed ID: 34542049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.
    Sun W; Ma X; Shen J; Yin F; Wang C; Cai Z
    Int J Mol Med; 2016 Aug; 38(2):466-74. PubMed ID: 27353415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioinformatics Analysis on Key Genes and Immune Infiltration of Osteosarcoma].
    Li S; Zheng ZZ; Zhang YP; Liu ZQ; Xiao SP; Ouyang ZX; Wang B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):110-117. PubMed ID: 35300772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis.
    Zhou X; Fan Y; Ye W; Jia B; Yang Y; Liu Y
    DNA Cell Biol; 2020 Jul; 39(7):1172-1180. PubMed ID: 32584170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioinformatics-based identification of key genes CDC5L and related pathways in osteosarcoma and Ewing's sarcoma].
    Feng N; Song WX; Shao LP; Gao YH; Zhao CW
    Zhongguo Gu Shang; 2022 Mar; 35(3):276-80. PubMed ID: 35322620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma.
    Li M; Jin X; Guo F; Wu G; Wu L; Deng S
    J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
    Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.
    Sun B; Wang F; Li M; Yang M
    Med Oncol; 2015 May; 32(5):153. PubMed ID: 25832865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma.
    Wang F; Qin G; Liu J; Wang X; Ye B
    Comput Math Methods Med; 2020; 2020():7067649. PubMed ID: 32855654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Analysis of Competing Endogenous RNAs Network Reveals Potential Signatures in Osteosarcoma Development.
    Heng L; Jia Z; Sun J; Zhao Y; Zhang K; Zhu Y; Lu S
    Technol Cancer Res Treat; 2020; 19():1533033820957025. PubMed ID: 32912111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
    Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
    BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN.
    Zhong B; Guo S; Zhang W; Zhang C; Wang Y; Zhang C
    BMC Med Genomics; 2017 Nov; 10(1):64. PubMed ID: 29141684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.